These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27383927)

  • 21. Reporting of Sociodemographic Variables in Randomized Clinical Trials, 2014-2020.
    Orkin AM; Nicoll G; Persaud N; Pinto AD
    JAMA Netw Open; 2021 Jun; 4(6):e2110700. PubMed ID: 34076703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allocation concealment in randomised controlled trials: are we getting better?
    Clark L; Fairhurst C; Torgerson DJ
    BMJ; 2016 Nov; 355():i5663. PubMed ID: 27856428
    [No Abstract]   [Full Text] [Related]  

  • 23. Bias in experimental study designs: randomised controlled trials with parallel groups.
    Sedgwick P
    BMJ; 2015 Jul; 351():h3869. PubMed ID: 26187730
    [No Abstract]   [Full Text] [Related]  

  • 24. [Not Available].
    Giulio Formoso, per l'Associazione Alessandro Liberati - Network italiano Cochrane
    Recenti Prog Med; 2019 Nov; 110(11):524-525. PubMed ID: 31808432
    [No Abstract]   [Full Text] [Related]  

  • 25. Statistical models appropriate for designs often used in group-randomized trials.
    Murray DM
    Stat Med; 2001 May 15-30; 20(9-10):1373-85. PubMed ID: 11343359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mixed randomized trial: combining randomized, pragmatic and observational clinical trial designs.
    Alsop J; Scott M; Archey W
    J Comp Eff Res; 2016 Nov; 5(6):569-579. PubMed ID: 27618500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RCTs and cessation frustration.
    Wickham S
    Pract Midwife; 2006 Feb; 9(2):35. PubMed ID: 16512034
    [No Abstract]   [Full Text] [Related]  

  • 28. U.S. Dietary Guidelines: An Evidence-Free Zone.
    Nissen SE
    Ann Intern Med; 2016 Apr; 164(8):558-9. PubMed ID: 26783992
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparing alternative design options for chronic disease prevention interventions.
    Golfam M; Beall R; Brehaut J; Saeed S; Relton C; Ashbury FD; Little J
    Eur J Clin Invest; 2015 Jan; 45(1):87-99. PubMed ID: 25388015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Added value of observational studies in surgery: the hierarchical structure of study designs requires a more refined approach].
    Beks RB; Houwert RM; Groenwold RHH
    Ned Tijdschr Geneeskd; 2017; 161():D1493. PubMed ID: 28488557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is reporting quality in medical publications associated with biostatisticians as co-authors? A registered report protocol.
    Held U; Steigmiller K; Hediger M; Gosteli M; Reeve KA; von Felten S; Furrer E
    PLoS One; 2020; 15(11):e0241897. PubMed ID: 33156885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rank minimization with a two-step analysis should not replace randomization in clinical trials.
    Morris T
    J Clin Epidemiol; 2012 Jul; 65(7):810-1. PubMed ID: 22564502
    [No Abstract]   [Full Text] [Related]  

  • 33. Randomised controlled trials may have many unrecognised potential biases.
    Hawkes N
    BMJ; 2018 Apr; 361():k1561. PubMed ID: 29622530
    [No Abstract]   [Full Text] [Related]  

  • 34. Considering race/ethnicity and socio-economic status in randomized controlled trials. A commentary on Frampton et al.'s systematic review generalizing trial findings and tackling health disparities in asthma research.
    Kreatsoulas C; Anand S
    Soc Sci Med; 2009 Oct; 69(8):1155-6. PubMed ID: 19640625
    [No Abstract]   [Full Text] [Related]  

  • 35. Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review.
    Vonbank A; Drexel H; Agewall S; Lewis BS; Dopheide JF; Kjeldsen K; Ceconi C; Savarese G; Rosano G; Wassmann S; Niessner A; Schmidt TA; Saely CH; Baumgartner I; Tamargo J
    Eur Heart J Cardiovasc Pharmacother; 2018 Oct; 4(4):230-236. PubMed ID: 30099530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Selection Bias on Treatment Effect Size Estimates in Randomized Trials of Oral Health Interventions: A Meta-epidemiological Study.
    Saltaji H; Armijo-Olivo S; Cummings GG; Amin M; da Costa BR; Flores-Mir C
    J Dent Res; 2018 Jan; 97(1):5-13. PubMed ID: 28813182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquiring Surgical Knowledge: Sound Methodology and Transparent Reporting.
    Buie WD
    Dis Colon Rectum; 2017 Jun; 60(6):565-566. PubMed ID: 28481849
    [No Abstract]   [Full Text] [Related]  

  • 38. Choosing covariates in the analysis of clinical trials.
    Beach ML; Meier P
    Control Clin Trials; 1989 Dec; 10(4 Suppl):161S-175S. PubMed ID: 2605965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world studies no substitute for RCTs in establishing efficacy.
    Gerstein HC; McMurray J; Holman RR
    Lancet; 2019 Jan; 393(10168):210-211. PubMed ID: 30663582
    [No Abstract]   [Full Text] [Related]  

  • 40. Bias: considerations for research practice.
    Gerhard T
    Am J Health Syst Pharm; 2008 Nov; 65(22):2159-68. PubMed ID: 18997149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.